No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study-Reference-Cited by-同舟云学术

No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study

Published:2022-01-20 Issue:1 Volume:11 Page:543-557
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Huang Yinqiu,He Xiaoqing,Chen Hui,Harypursat Vijay,Lu Yanqiu,Yuan Jing,Nie Jingmin,Liu Min,Yu Jianhua,Zhang Yulin,Jiang Zhongsheng,Qin Yingmei,Xu Lijun,Zhou Guoqiang,Zhang Defa,Chen Xiaohong,Zheng Baisong,Chen Yaokai

Funder

the National Science and Technology Major Project of China During the 13th Five-year Plan Period

the Medical Research Projects of Chongqing Municipal Science and Technology Bureau and Health Commission

the Chongqing Science and Technology Bureau Project

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00586-5.pdf

Reference23 articles.

1. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect Dis Clin N Am. 2010;24(1):107–38.